Literature DB >> 18936207

Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR:LA-cp rats.

Ye Wang1, Jing Lu, Megan R Ruth, Sue D Goruk, Martin J Reaney, David R Glimm, Donna F Vine, Catherine J Field, Spencer D Proctor.   

Abstract

Trans-11 vaccenic acid [VA; 18:1(n-9)] is a positional and geometric isomer of oleic acid and is the precursor to conjugated linoleic acid (CLA) in humans. Despite VA being the predominant trans monoene in ruminant-derived lipids, very little is known about its nutritional bioactivity, particularly in conditions of chronic metabolic disorders, including obesity, insulin resistance, and/or dyslipidemia. The aim of this study was to assess the potential of VA to improve dyslipidemia, insulin sensitivity, or inflammatory status in obese and insulin-resistant JCR:LA-cp rats. The obese rats and age-matched lean littermates were fed a control diet or a control diet supplemented with 1.5% (wt:wt) VA for a period of 3 wk. The incorporation of VA and subsequent conversion to CLA in triglyceride was measured in adipose tissue. Glucose and insulin metabolism were assessed via a conscious adapted meal tolerance test procedure. Plasma lipids as well as serum inflammatory cytokine concentrations were measured by commercially available assays. VA supplementation did not result in any observable adverse health effects in either lean or obese JCR:LA-cp rats. After 3 wk of feeding, body weight, food intake, and glucose/insulin metabolism did not differ between VA-supplemented and control groups. The incorporation of VA and CLA into adipose triglycerides in obese rats fed VA increased by 1.5-fold and 6.5-fold, respectively, compared with obese rats fed the control diet. The most striking effect was a 40% decrease (P < 0.05) in fasting triglyceride concentrations in VA-treated obese rats relative to obese controls. Serum Il-10 concentration was decreased by VA, regardless of genotype (P < 0.05). In conclusion, short-term dietary supplementation of 1.5% VA did not result in any detrimental metabolic effects in JCR:LA-cp rats. In contrast, dietary VA had substantial hypo-triglyceridemic effects, suggesting a new bioactivity of this fatty acid that is typically found in ruminant-derived food products.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936207     DOI: 10.3945/jn.108.091009

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  19 in total

1.  Physiological concentrations of trans-11 18:1 vaccenic acid suppress pro-inflammatory markers under acute inflammation in isolated ICR mice splenocytes.

Authors:  Jae-Sung Lee; Ji-Na Lim; Tao Wang; Sang-Bum Lee; Jin-Hee Hwang; U-Suk Jung; Min-Jeong Kim; Seong-Ho Choi; Satoshi Ishizuka; Hong-Gu Lee
Journal:  Food Sci Biotechnol       Date:  2016-02-29       Impact factor: 2.391

2.  Two fatty acid elongases possessing C18-Δ6/C18-Δ9/C20-Δ5 or C16-Δ9 elongase activity in Thraustochytrium sp. ATCC 26185.

Authors:  Junichiro Ohara; Keishi Sakaguchi; Yuji Okita; Nozomu Okino; Makoto Ito
Journal:  Mar Biotechnol (NY)       Date:  2013-04-02       Impact factor: 3.619

Review 3.  Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies.

Authors:  Sarah K Gebauer; Jean-Michel Chardigny; Marianne Uhre Jakobsen; Benoît Lamarche; Adam L Lock; Spencer D Proctor; David J Baer
Journal:  Adv Nutr       Date:  2011-06-28       Impact factor: 8.701

4.  Erythrocyte trans-fatty acids, type 2 diabetes and cardiovascular risk factors in middle-aged and older Chinese individuals.

Authors:  D X Yu; Q Sun; X W Ye; A Pan; G Zong; Y H Zhou; H X Li; F B Hu; X Lin
Journal:  Diabetologia       Date:  2012-08-12       Impact factor: 10.122

5.  Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat.

Authors:  M Miriam Jacome-Sosa; Jing Lu; Ye Wang; Megan R Ruth; David C Wright; Martin J Reaney; Jianheng Shen; Catherine J Field; Donna F Vine; Spencer D Proctor
Journal:  Nutr Metab (Lond)       Date:  2010-07-16       Impact factor: 4.169

6.  Vaccenic and elaidic acid modify plasma and splenocyte membrane phospholipids and mitogen-stimulated cytokine production in obese insulin resistant JCR: LA-cp rats.

Authors:  Megan R Ruth; Ye Wang; Howe-Ming Yu; Susan Goruk; Martin J Reaney; Spencer D Proctor; Donna F Vine; Catherine J Field
Journal:  Nutrients       Date:  2010-02-11       Impact factor: 5.717

Review 7.  Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials.

Authors:  Constance Gayet-Boyer; Fanny Tenenhaus-Aziza; Caroline Prunet; Corinne Marmonier; Corinne Malpuech-Brugère; Benoit Lamarche; Jean-Michel Chardigny
Journal:  Br J Nutr       Date:  2014-10-27       Impact factor: 3.718

8.  Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR:LA-cp rat.

Authors:  Miriam Jacome-Sosa; Claudia Vacca; Rabban Mangat; Abdoulaye Diane; Randy C Nelson; Martin J Reaney; Jianheng Shen; Jonathan M Curtis; Donna F Vine; Catherine J Field; Miki Igarashi; Daniele Piomelli; Sebastiano Banni; Spencer D Proctor
Journal:  J Lipid Res       Date:  2016-02-17       Impact factor: 5.922

9.  Plasma concentration of cis9trans11 CLA in males and females is influenced by SCD1 genetic variations and hormonal contraceptives: a cross-sectional study.

Authors:  Salma A Abdelmagid; Shannon E Clarke; Jeremy Wong; Kaitlin Roke; Daiva Nielsen; Alaa Badawi; Ahmed El-Sohemy; David M Mutch; David Wl Ma
Journal:  Nutr Metab (Lond)       Date:  2013-07-18       Impact factor: 4.169

10.  Plasma phospholipid trans-fatty acids levels, cardiovascular diseases, and total mortality: the cardiovascular health study.

Authors:  Qianyi Wang; Fumiaki Imamura; Rozenn N Lemaitre; Eric B Rimm; Molin Wang; Irena B King; Xiaoling Song; David Siscovick; Dariush Mozaffarian
Journal:  J Am Heart Assoc       Date:  2014-08-27       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.